APA (7th ed.) Citation

Mathad, J. S., Savic, R., Britto, P., Jayachandran, P., Wiesner, L., Montepiedra, G., . . . Dooley, K. E. (2022). Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women. Clinical Infectious Diseases, 74(9), 1604. https://doi.org/10.1093/cid/ciab665

Chicago Style (17th ed.) Citation

Mathad, Jyoti S., et al. "Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women." Clinical Infectious Diseases 74, no. 9 (2022): 1604. https://doi.org/10.1093/cid/ciab665.

MLA (9th ed.) Citation

Mathad, Jyoti S., et al. "Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women." Clinical Infectious Diseases, vol. 74, no. 9, 2022, p. 1604, https://doi.org/10.1093/cid/ciab665.